Market expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to potential Iran-US war impacts. Mehta favors pharma stocks for their growth potential and attractive valuations. Specialty chemicals are seen entering an upcycle. He suggests caution on cable stocks due to valuations. Auto stocks remain a preferred sector for investment.